Related references
Note: Only part of the references are listed.Analysis of the mutational status of SIX1/2 and microRNA processing genes in paired primary and relapsed Wilms tumors and association with relapse
Sara Ciceri et al.
CANCER GENE THERAPY (2021)
St. Jude Cloud: A Pediatric Cancer Genomic Data-Sharing Ecosystem
Clay McLeod et al.
CANCER DISCOVERY (2021)
Transcriptomic Analyses of MYCN-Regulated Genes in Anaplastic Wilms' Tumour Cell Lines Reveals Oncogenic Pathways and Potential Therapeutic Vulnerabilities
Marianna Szemes et al.
CANCERS (2021)
Wilms tumour
Filippo Spreafico et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
High-risk blastemal Wilms tumor can be modeled by 3D spheroid cultures in vitro
Jenny Wegert et al.
ONCOGENE (2020)
DNA hypermethylation within TERT promoter upregulates TERT expression in cancer (vol 129, pg 223, 2019)
Donghyun D. Lee et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players
Xiaotian Yuan et al.
ONCOGENE (2019)
Forty-five patient-derived xenografts capture the clinical and biological heterogeneity of Wilms tumor
Andrew J. Murphy et al.
NATURE COMMUNICATIONS (2019)
CRIS.py: A Versatile and High-throughput Analysis Program for CRISPR-based Genome Editing
Jon P. Connelly et al.
SCIENTIFIC REPORTS (2019)
A Survey of Validation Strategies for CRISPR-Cas9 Editing
Monica F. Sentmanat et al.
SCIENTIFIC REPORTS (2018)
A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor
Samantha Gadd et al.
NATURE GENETICS (2017)
Telomeres in cancer: tumour suppression and genome instability
John Maciejowski et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Treating Cancer by Targeting Telomeres and Telomerase
Marko Ivancich et al.
ANTIOXIDANTS (2017)
Significance of TP53 Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group
Ariadne H. A. G. Ooms et al.
CLINICAL CANCER RESEARCH (2016)
Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences
Sebastian Moran et al.
EPIGENOMICS (2016)
Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies
Mohammad A. Jafri et al.
GENOME MEDICINE (2016)
Recurrent DGCR8, DROSHA, and SIX Homeodomain Mutations in Favorable Histology Wilms Tumors
Amy L. Walz et al.
CANCER CELL (2015)
Mutations in the SIX1/2 Pathway and the DROSHA/DGCR8 miRNA Microprocessor Complex Underlie High-Risk Blastemal Type Wilms Tumors
Jenny Wegert et al.
CANCER CELL (2015)
Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG)
M. M. van den Heuvel-Eibrink et al.
EUROPEAN JOURNAL OF CANCER (2015)
The yin and yang of kidney development and Wilms' tumors
Peter Hohenstein et al.
GENES & DEVELOPMENT (2015)
Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration
Jeffrey S. Dome et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Telomerase activation by genomic rearrangements in high-risk neuroblastoma
Martin Peifer et al.
NATURE (2015)
The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
Robert J. A. Bell et al.
SCIENCE (2015)
Multiple mechanisms of MYCN dysregulation in Wilms tumour
Richard D. Williams et al.
ONCOTARGET (2015)
TP53 Mutational Status Is a Potential Marker for Risk Stratification in Wilms Tumour with Diffuse Anaplasia
Mariana Maschietto et al.
PLOS ONE (2014)
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
Marc Remke et al.
ACTA NEUROPATHOLOGICA (2013)
Identification of molecular compartments and genetic circuitry in the developing mammalian kidney
Jing Yu et al.
DEVELOPMENT (2012)
Characterization of 17.94, a novel anaplastic Wilms' tumor cell line
Keith W. Brown et al.
CANCER GENETICS (2012)
The GUDMAP database - an online resource for genitourinary research
Simon D. Harding et al.
DEVELOPMENT (2011)
Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation
Qianghua Hu et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene
Vicki Huff
NATURE REVIEWS CANCER (2011)
GUDMAP: The Genitourinary Developmental Molecular Anatomy Project
Andrew P. McMahon et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study group
Marcio Malogolowkin et al.
PEDIATRIC BLOOD & CANCER (2008)
The Wilms tumor gene, Wt1, is required for Sox9 expression and maintenance of tubular architecture in the developing testis
Fei Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor
JS Dome et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Derivation and characterization of a Wilms' tumour cell line, WiT 49
J Alami et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
MethPrimer: designing primers for methylation PCRs
LC Li et al.
BIOINFORMATICS (2002)
Cooperation between p53 mutation and high telomerase transgenic expression in spontaneous cancer development
E González-Suárez et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: A tool for temporally regulated gene activation/inactivation in the mouse
S Hayashi et al.
DEVELOPMENTAL BIOLOGY (2002)
Share Paper
